Literature DB >> 12727918

Tissue glycogen content and glucose intolerance.

Masato Kasuga1, Wataru Ogawa, Takeshi Ohara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12727918      PMCID： PMC154454          DOI： 10.1172/JCI18526

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  20 in total

Review 1.  Mouse models of insulin resistance.

Authors:  Marta Letizia Hribal; Francesco Oriente; Domenico Accili
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-05       Impact factor: 4.310

2.  Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.

Authors:  L Ryysy; A M Häkkinen; T Goto; S Vehkavaara; J Westerbacka; J Halavaara; H Yki-Järvinen
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

3.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

Authors:  G I Shulman; D L Rothman; T Jue; P Stein; R A DeFronzo; R G Shulman
Journal:  N Engl J Med       Date:  1990-01-25       Impact factor: 91.245

4.  Direct measurement of change in muscle glycogen concentration after a mixed meal in normal subjects.

Authors:  R Taylor; T B Price; L D Katz; R G Shulman; G I Shulman
Journal:  Am J Physiol       Date:  1993-08

5.  Disruption of the striated muscle glycogen targeting subunit PPP1R3A of protein phosphatase 1 leads to increased weight gain, fat deposition, and development of insulin resistance.

Authors:  Mirela Delibegovic; Christopher G Armstrong; Lorraine Dobbie; Peter W Watt; Andrew J H Smith; Patricia T W Cohen
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

6.  Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G/RGL.

Authors:  Y Suzuki; C Lanner; J H Kim; P G Vilardo; H Zhang; J Yang; L D Cooper; M Steele; A Kennedy; C B Bock; A Scrimgeour; J C Lawrence; A A DePaoli-Roach
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

7.  PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance.

Authors:  Sean M Crosson; Ahmir Khan; John Printen; Jeffrey E Pessin; Alan R Saltiel
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

8.  Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study.

Authors:  I Magnusson; D L Rothman; L D Katz; R G Shulman; G I Shulman
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

9.  A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin.

Authors:  L Hansen; T Hansen; H Vestergaard; C Bjørbaek; S M Echwald; J O Clausen; Y H Chen; M X Chen; P T Cohen; O Pedersen
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

10.  Lipogenesis in situ in the genetically obese Zucker fatty rat (fa/fa): role of hyperphagia and hyperinsulinaemia.

Authors:  V Godbole; D A York
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122
View more
  6 in total

1.  Role of Fas-associated death domain-containing protein (FADD) phosphorylation in regulating glucose homeostasis: from proteomic discovery to physiological validation.

Authors:  Chun Yao; Hongqin Zhuang; Pan Du; Wei Cheng; Bingya Yang; Shengwen Guan; Yun Hu; Dalong Zhu; Miller Christine; Lv Shi; Zi-Chun Hua
Journal:  Mol Cell Proteomics       Date:  2013-07-04       Impact factor: 5.911

2.  trans-10,cis-12 conjugated linoleic acid enhances endurance capacity by increasing fatty acid oxidation and reducing glycogen utilization in mice.

Authors:  Jun Ho Kim; Jonggun Kim; Yeonhwa Park
Journal:  Lipids       Date:  2012-07-11       Impact factor: 1.880

3.  Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease.

Authors:  Gaelle Douillard-Guilloux; Nina Raben; Shoichi Takikita; Arnaud Ferry; Alban Vignaud; Isabelle Guillet-Deniau; Maryline Favier; Beth L Thurberg; Peter J Roach; Catherine Caillaud; Emmanuel Richard
Journal:  Hum Mol Genet       Date:  2009-12-03       Impact factor: 6.150

4.  AJS1669, a novel small-molecule muscle glycogen synthase activator, improves glucose metabolism and reduces body fat mass in mice.

Authors:  Kazuhiro Nakano; Sen Takeshita; Noriko Kawasaki; Wataru Miyanaga; Yoriko Okamatsu; Mizuki Dohi; Tadakiyo Nakagawa
Journal:  Int J Mol Med       Date:  2017-03-07       Impact factor: 4.101

5.  Impaired glucose metabolism and exercise capacity with muscle-specific glycogen synthase 1 (gys1) deletion in adult mice.

Authors:  Chrysovalantou E Xirouchaki; Salvatore P Mangiafico; Katherine Bate; Zheng Ruan; Amy M Huang; Bing Wilari Tedjosiswoyo; Benjamin Lamont; Wynne Pong; Jenny Favaloro; Amy R Blair; Jeffrey D Zajac; Joseph Proietto; Sofianos Andrikopoulos
Journal:  Mol Metab       Date:  2016-01-21       Impact factor: 7.422

6.  d-Allulose Improves Endurance and Recovery from Exhaustion in Male C57BL/6J Mice.

Authors:  Bingyang Liu; Yang Gou; Takamasa Tsuzuki; Takako Yamada; Tetsuo Iida; Sixian Wang; Ryoichi Banno; Yukiyasu Toyoda; Teruhiko Koike
Journal:  Nutrients       Date:  2022-01-18       Impact factor: 5.717
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.